Document is current
Any future updates will be listed below
-
Authors
Dong, Haiyan
Wen, Chuangyu
He, Lu
Zhang, Jingdan
Xiang, Nanlin
Liang, Liumei
Hu, Limei
Li, Weiqian
Liu, Jiaqi
Shi, Mengchen
Hu, Yijia
Chen, Siyu
Liu, Huanliang http://orcid.org/0000-0002-1006-6666
Yang, Xiangling
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82172337)
Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515012530, 2022A1515011316, 2022A1515140001, 2023A1515012377)
Guangdong Provincial Clinical Research Center for Digestive Diseases (2020B1111170004)
National Key Clinical Discipline
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 4 August 2024
First Online: 14 August 2024
Declarations
:
: All procedures in animal experiments were conducted following the principles of Animal Research: Reporting of In Vivo Experiments (ARRIVE) 2.0 guidelines and the Basel Declaration. All animal studies were approved by the Committee on the Ethics of Animal Experiments of the Sixth Affiliated Hospital, Sun Yat-sen University (IACUC-2020122502 and IACUC-2021110401). Tissue chip microarray of human colon cancer and adjacent normal tissues (HColA180Su12) was purchased from Shanghai Outdo Biotech Co., Ltd. The study was conducted following the principles of the Declaration of Helsinki and approved by the Ethics Committee of Shanghai Outdo Biotech Co., Ltd. (SHYJS-CP-1607002).
: Not applicable.
: The authors declare no competing interests.
